Pricing Log in Create free account

Definium Therapeutics, Inc. (DFTX) vs PTC Therapeutics, Inc. (PTCT)

Definium Therapeutics, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. PTC Therapeutics, Inc. is the larger, with a market value of $5.1B against $4.6B — 1.1× the size. Definium Therapeutics, Inc. has the higher net margin (0.00% vs −3.80%) and the lower return on invested capital (0.00% vs 15.2%). Across the 13 metrics below, PTC Therapeutics, Inc. leads on 9 and Definium Therapeutics, Inc. on 4.

Valuation

Metric DFTX PTCT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.87 9.71
P/B 3.87 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 34.41 0.64
EV/Sales n/m 5.55 9.21
Earnings yield (10.69%) (0.83%) (33.15%)
Free cash flow yield (4.73%) (6.11%) (25.50%)

Profitability

Metric DFTX PTCT Biotechnology median
Gross margin 0.00% 92.99% 65.16%
Operating margin 0.00% 12.45% 0.00%
Net margin 0.00% (3.80%) 0.00%
Free cash flow margin 0.00% (29.76%) 0.00%
Return on equity (64.09%) 20.64% (56.36%)
Return on assets (51.35%) (1.30%) (48.04%)
Return on invested capital 0.00% 15.16% 0.00%

Growth

Metric DFTX PTCT Biotechnology median
Revenue growth (TTM) — (42.84%) 6.02%
EPS growth (last fiscal year) (33.77%) 264.48% 30.26%
Revenue growth, 5-year CAGR — 35.37% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DFTX PTCT Biotechnology median
Debt to equity 0.04 (17.61) 0.00
Current ratio 6.95 3.39 4.72
Net debt to EBITDA 2.21 0.73 0.96

Dividend

Metric DFTX PTCT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DFTX PTCT Biotechnology median
Market cap 4.60b 5.09b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack